Carregant...
Clinical characteristics and PD-L1 expression in primary lung squamous cell carcinoma: A case series
BACKGROUND: Squamous cell lung carcinoma(SCLC), accounts for 20% of lung cancer(LC). The binding of programmed cell death 1(PD-1) to its ligand PD-L1 is a key checkpoint regulator of immune response, and overexpression of the latter leads to immune surveillance escape. This might represent an import...
Guardat en:
| Publicat a: | Respir Med Case Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7287140/ https://ncbi.nlm.nih.gov/pubmed/32551224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101114 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|